Ultrasensitive prostate-specific antigen level as a predictor of biochemical progression after robot-assisted radical prostatectomy: Towards risk adapted follow-up-Reference-Cited by-同舟云学术

Ultrasensitive prostate-specific antigen level as a predictor of biochemical progression after robot-assisted radical prostatectomy: Towards risk adapted follow-up

Published:2018-10-26 Issue:2 Volume:33 Page:e22693
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:J Clin Lab Anal

Author:

Grivas Nikolaos¹^ORCID,de Bruin Daan²,Barwari Kurdo³,van Muilekom Erik¹,Tillier Corinne¹,van Leeuwen Pim J.¹,Wit Esther¹,Kroese Wouter²,van der Poel Henk¹

Affiliation:

1. Department of Urology; The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital; Amsterdam The Netherlands

2. Pacmed; Amsterdam The Netherlands

3. Department of Urology; VU University Medical Centre; Amsterdam The Netherlands

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry, medical,Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcla.22693/fullpdf

Reference29 articles.

1. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate;Oesterling;J Urol,1991

2. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer;Catalona;N Engl J Med,1991

3. The clinical usefulness of prostate specific antigen: update 1994;Partin;J Urol,1994

4. Guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent;Mottet;Eur Urol,2017

5. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy;Stephenson;J Natl Cancer Inst,2006

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Investigational Treatment Analysis of Novel Anti‐androgen (TITAN) study: ultralow prostate‐specific antigen decline with apalutamide plus androgen‐deprivation therapy;BJU International;2024-06-28

2. Prostate-Specific Antigen as an Ultrasensitive Biomarker for Patients with Early Recurrent Prostate Cancer: How Low Shall We Go? A Systematic Review;Biomedicines;2024-04-08

3. Optimizing anti-androgen treatment use among men with pathologic lymph-node positive prostate cancer treated with radical prostatectomy: the importance of postoperative PSA kinetics;Prostate Cancer and Prostatic Diseases;2022-07-06

4. Salvage Radiotherapy versus Observation for Biochemical Recurrence following Radical Prostatectomy for Prostate Cancer: A Matched Pair Analysis;Cancers;2022-01-31

5. Early prediction of prostate cancer biochemical recurrence and identification of disease persistence using PSA isoforms and human kallikrein-2;Tumor Biology;2021-08-24